|
Index of reports
> Cases with Sepsis (119)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 119 Next >>
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 15.2 kg (33.4 pounds)
Reactions: Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ilaris
Dosage: 60.3 mg, unk
Indication: Juvenile Arthritis
Start date: 2012-05-14
Prednisolone
Possible Prednisolone side effects in male
Reported by a physician from United Kingdom on 2012-08-21
Patient: male
Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Azathioprine Sodium
Dosage: 2.5 mg/kg
Indication: Crohn's Disease
Azathioprine Sodium
Start date: 2002-01-01
End date: 2006-09-01
Azathioprine Sodium
Start date: 2001-06-01
Mercaptopurine
Indication: Crohn's Disease
Prednisolone
Indication: Product Used FOR Unknown Indication
Remicade
Indication: Crohn's Disease
End date: 2005-09-29
Remicade
Dosage: stopped in february - march (3rd infusion)
End date: 2006-02-01
Other drugs received by patient: Metronidazole; Vitamin B-12
Possible Prednisolone side effects in female
Reported by a individual with unspecified qualification from Japan on 2012-08-09
Patient: female, weighing 33.0 kg (72.6 pounds)
Reactions: Neutrophil Count Increased, Nausea, Diarrhoea, Sepsis, Asthenia, Decreased Appetite, Lymphocyte Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: daily dosage unknown
Administration route: Oral
Start date: 2011-01-11
End date: 2011-03-15
Temodal
Start date: 2011-06-22
End date: 2011-06-26
Temodal
Start date: 2011-01-19
End date: 2011-03-01
Temodal
Temodal
Start date: 2011-04-14
End date: 2011-04-18
Temodal
Start date: 2011-07-19
End date: 2011-07-23
Temodal
Start date: 2011-03-17
End date: 2011-03-21
Temodal
Start date: 2011-05-16
End date: 2011-05-20
Temozolomide
Dosage: 150 mg/m2, qd
Start date: 2011-03-17
End date: 2011-03-21
Temozolomide
Dosage: 200 mg/m2, qd
Start date: 2011-04-14
End date: 2011-07-23
Temozolomide
Dosage: 75 mg/m2, qd
Indication: Anaplastic Astrocytoma
Start date: 2011-01-19
End date: 2011-03-01
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Neuquinon; Neuquinon; Indomethacin; Cefazolin Sodium; Diovan; Lansoprazole; Magnesium Oxide; Granisetron; Diovan; Laxoberon; Simvastatin; Sulfamethoxazole and Trimethoprim; Neuquinon; Tegretol; Primperan TAB; Lorazepam; Prednisolone; Lansoprazole; Zolpidem; Simvastatin; Tegretol; Warfarin Sodium; Lorazepam; Urso 250; Warfarin Potassium; Warfarin Sodium
Possible Prednisolone side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-08-07
Patient: 52 year old male
Reactions: Malignant Ascites, Sepsis, General Physical Health Deterioration, non-Hodgkin's Lymphoma, Post Procedural Fistula, Respiratory Tract Infection, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mesalamine
Indication: Crohn's Disease
Prednisolone
Indication: Crohn's Disease
Possible Prednisolone side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-03
Patient: 42 year old male
Reactions: Blood Creatine Phosphokinase Increased, Gastrointestinal Haemorrhage, Colitis Ulcerative, Transfusion Reaction, Muscular Weakness, Condition Aggravated, Encephalitis Viral, Myalgia, Sepsis, Nervous System Disorder, Renal Tubular Necrosis, Asthenia, Deep Vein Thrombosis, Renal Failure Acute, Inflammatory Bowel Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adalimumab
Dosage: 1 every 2 weeks for 2 doses
Indication: Colitis Ulcerative
Adalimumab
Azathioprine Sodium
Dosage: 50 to 150 mg once daily
Indication: Colitis Ulcerative
Mesalamine
Mesalamine
Administration route: Oral
Indication: Colitis Ulcerative
Mesalamine
Prednisolone
Dosage: 10 to 60 mg once daily
Administration route: Oral
Indication: Colitis Ulcerative
Probiotica
Indication: Colitis Ulcerative
Remicade
Indication: Colitis Ulcerative
Possible Prednisolone side effects in 77 year old female
Reported by a physician from Japan on 2012-08-01
Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Blood Urea Increased, Pneumonia, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Exjade
Dosage: 625 mg, qd
Administration route: Oral
Start date: 2011-05-07
End date: 2011-05-18
Exjade
Dosage: 625 mg, on alternate days
Administration route: Oral
Start date: 2011-05-19
Exjade
Dosage: 750 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2009-09-16
End date: 2011-04-03
Prednisolone
Dosage: 5 mg daily
Administration route: Oral
Start date: 2010-04-22
Prednisolone
Dosage: 8 mg, daily
Administration route: Oral
End date: 2009-09-29
Prednisolone
Dosage: 7 mg, daily
Administration route: Oral
Start date: 2009-09-30
End date: 2010-02-02
Prednisolone
Dosage: 6 mg, daily
Administration route: Oral
Start date: 2010-02-03
End date: 2010-04-21
Prednisolone
Dosage: 4 mg, unk
Administration route: Oral
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2011-04-12
End date: 2011-05-02
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-05-19
End date: 2011-06-01
Other drugs received by patient: Equa; Xalatan; Desferal; Famotidine; Novolin R; RED Blood Cells, Concentrated; Glufast; Novolin R; RED Blood Cells, Concentrated; Alendronate Sodium; Timoptol-XE; Platelets; Novolin R; Amaryl; Novolin R; Azopt; Platelets; Famotidine; Glufast; Clarithromycin; Desferal; Desferal; Mucodyne; Voglibose
Possible Prednisolone side effects in 77 year old female
Reported by a physician from Japan on 2012-08-01
Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Pneumonia, Blood Urea Increased, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Exjade
Dosage: 750 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2009-09-16
End date: 2011-04-03
Exjade
Dosage: 625 mg, on alternate days
Administration route: Oral
Start date: 2011-05-19
Exjade
Dosage: 625 mg, qd
Administration route: Oral
Start date: 2011-05-07
End date: 2011-05-18
Prednisolone
Dosage: 8 mg, daily
Administration route: Oral
End date: 2009-09-29
Prednisolone
Dosage: 7 mg, daily
Administration route: Oral
Start date: 2009-09-30
End date: 2010-02-02
Prednisolone
Dosage: 6 mg, daily
Administration route: Oral
Start date: 2010-02-03
End date: 2010-04-21
Prednisolone
Dosage: 4 mg, unk
Administration route: Oral
Prednisolone
Dosage: 5 mg daily
Administration route: Oral
Start date: 2010-04-22
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2011-04-12
End date: 2011-05-02
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-05-19
End date: 2011-06-01
Other drugs received by patient: Platelets; Novolin R; Clarithromycin; Xalatan; Desferal; Novolin R; RED Blood Cells, Concentrated; Mucodyne; Famotidine; Famotidine; Azopt; Platelets; Desferal; RED Blood Cells, Concentrated; Alendronate Sodium; Voglibose; Timoptol-XE; Amaryl; Novolin R; Novolin R; Glufast; Glufast; Desferal; Equa
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-08-01
Patient: male, weighing 55.0 kg (121.0 pounds)
Reactions: Hydronephrosis, Cholecystitis Acute, Disseminated Intravascular Coagulation, Gastric Ulcer, Haemorrhage Subcutaneous, Spinal Compression Fracture, Sepsis, Platelet Count Decreased, Cholecystitis, Pyelonephritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actemra
Start date: 2009-03-05
End date: 2009-03-05
Actemra
Indication: Rheumatoid Arthritis
Start date: 2009-02-05
End date: 2009-02-05
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Tacrolimus
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Crestor; Zantac; Lasix; Loxonin; Methotrexate; Alfarol; Glakay; Alendronate Sodium; Flivas; Amoban; Tamsulosin HCL; Methotrexate; Isoniazid; Vitamin B12; Folic Acid; Allopurinol
Possible Prednisolone side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-31
Patient:
Reactions: Neutropenic Sepsis, Sepsis, Dyspraxia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: B-Cell Lymphoma
Prednisolone
Dosage: on day 1-5
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisolone side effects in
Reported by a consumer/non-health professional from Japan on 2012-07-27
Patient:
Reactions: Neutrophil Count Increased, Diarrhoea, Nausea, Sepsis, Asthenia, Lymphocyte Count Decreased, Decreased Appetite
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: daily dosage unknown
Administration route: Oral
Start date: 2011-01-11
End date: 2011-03-15
Temodal
Start date: 2011-05-16
End date: 2011-05-20
Temodal
Start date: 2011-07-19
End date: 2011-07-23
Temodal
Start date: 2011-06-22
End date: 2011-06-26
Temodal
Start date: 2011-01-19
End date: 2011-03-01
Temodal
Start date: 2011-03-17
End date: 2011-03-21
Temodal
Start date: 2011-04-14
End date: 2011-04-18
Temodal
Temozolomide
Dosage: 75 mg/m2, qd
Indication: Anaplastic Astrocytoma
Start date: 2011-01-19
End date: 2011-03-01
Temozolomide
Dosage: 150 mg/m2, qd
Start date: 2011-03-17
End date: 2011-03-21
Temozolomide
Dosage: 200 mg/m2, qd
Start date: 2011-04-14
End date: 2011-07-23
Other drugs received by patient: Warfarin Sodium; Warfarin Potassium; Laxoberon; Granisetron; Tegretol; Indomethacin; Warfarin Sodium; Neuquinon; Neuquinon; Neuquinon; Lorazepam; Magnesium Oxide; Sulfamethoxazole and Trimethoprim; Diovan; Lorazepam; Tegretol; Urso 250; Zolpidem; Diovan; Simvastatin; Prednisolone; Cefazolin Sodium; Lansoprazole; Sulfamethoxazole and Trimethoprim; Lansoprazole; Primperan TAB; Simvastatin
Possible Prednisolone side effects in female
Reported by a physician from Belgium on 2012-07-19
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Multi-Organ Failure, Cardiac Failure, Sepsis, Dehydration, Muscular Weakness, Atrial Fibrillation, Asthenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 100 dosage forms;
Start date: 2012-06-22
Treanda
Start date: 2012-06-21
Other drugs received by patient: Acyclovir; Anastrozole; Atorvastatin Calcium; Pregabalin; Domperidone; Omeprazole; Ondansetron; Bisoprolol Fumarate
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: male
Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Mycophenolate Mofetil
Indication: Renal Transplant
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
End date: 2011-03-15
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
End date: 2011-03-18
Prograf
Dosage: 2 mg, daily
Administration route: Oral
End date: 2011-11-17
Rituximab
Dosage: unk ukn, unk
Other drugs received by patient: Insulin
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: male
Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Bredinin
Dosage: 100 mg, daily
Administration route: Oral
End date: 2011-03-08
Mycophenolate Mofetil
Indication: Renal Transplant
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Indication: Renal Transplant
End date: 2011-03-15
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Start date: 2010-11-18
End date: 2011-03-15
Prednisolone
Dosage: 10 mg, daily
Administration route: Oral
End date: 2011-03-18
Prednisolone
Dosage: 10 mg, unk
End date: 2011-03-22
Prograf
Dosage: 2 mg, daily
Administration route: Oral
End date: 2011-11-17
Rituximab
Dosage: unk ukn, unk
Other drugs received by patient: Insulin
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2
Cyclophosphamide
Dosage: 250 mg/m2, bid for six doses
Indication: non-Hodgkin's Lymphoma
Cytarabine
Dosage: 100 mg/m2, daily x 5 days
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 30 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 60 mg/m2, single
Hydrocortisone Acetate
Dosage: given with methotrexate
Indication: non-Hodgkin's Lymphoma
Hydrocortisone Acetate
Dosage: given with cytarabine
Methotrexate
Dosage: 3000 mg/m2, single
Methotrexate
Dosage: given with hydrocortisone twice x 2
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 1500 mg/m2, single
Prednisolone
Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
Indication: non-Hodgkin's Lymphoma
Prednisolone
Dosage: 60 mg/m2, daily for 7 days
Rituximab
Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg/m2, single
Vincristine
Dosage: 1 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-06
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Sepsis, Disseminated Intravascular Coagulation, Pelvic Abscess
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actemra
Indication: Rheumatoid Arthritis
Start date: 2009-12-15
End date: 2011-12-22
Methotrexate Sodium
Administration route: Oral
Indication: Rheumatoid Arthritis
Prednisolone
Indication: Rheumatoid Arthritis
Other drugs received by patient: Diclofenac Sodium; Azulfidine
Possible Prednisolone side effects in 77 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-06
Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-30
Pinorubin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-25
Prednisolone
Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-31
Sprycel
Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-28
End date: 2010-08-22
Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-29
Patient: male
Reactions: Pneumonia, Staphylococcal Infection, Cardiac Failure, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Actemra
Dosage: 560 mg hver 4. uge
Indication: Rheumatoid Arthritis
Start date: 2010-08-01
End date: 2012-02-23
Methotrexate
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Prednisolone
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Possible Prednisolone side effects in female
Reported by a physician from Germany on 2012-06-28
Patient: female
Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Sepsis, Hypotension, Presyncope, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin HCL
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Mabthera
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Neulasta
Dosage: daily dose 6 mg, 2 x(29 apr 2012+17 may 2012
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Prednisolone
Dosage: frequency 1 times in 2 week for 5 days
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Other drugs received by patient: Enoxaparin Natrium; Aspirin; Ramipril; Tiotropium Bromide; Nebivolol; Torsemide; Pantoprazole; Levothyroxine Sodium; Acyclovir; Simvastatin; Trimethoprim + Sulfamethoxazole
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26
Patient: female
Reactions: Syncope, Sepsis, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1493 m
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin HCL
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Neulasta
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Prednisolone
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Rituximab
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Vincristine
Dosage: 3.94 m
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Other drugs received by patient: Simvastatin; Levothyroxine; Ramipril; Acyclovir; Acetylsalicylic Acid SRT; Enoxaparin Sodium; Tiotropium Bromide; Trimethoprim + Sulfamethoxazole; Torsemide; Pantoprazole; Nebivolol
Possible Prednisolone side effects in 66 year old female
Reported by a physician from Finland on 2012-06-26
Patient: 66 year old female
Reactions: Swelling Face, Nausea, Hepatic Enzyme Increased, Acute Tonsillitis, Sepsis, Neutropenia, Rash Morbilliform, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 10 mg, unk
Indication: Seronegative Arthritis
Start date: 2012-01-01
Sulfasalazine
Dosage: unk
Indication: Seronegative Arthritis
Start date: 2012-01-01
End date: 2012-05-01
Other drugs received by patient: Calcium Carbonate; Pantoprazole
Possible Prednisolone side effects in male
Reported by a physician from Denmark on 2012-06-25
Patient: male
Reactions: Pneumonia, Staphylococcal Infection, Cardiac Failure, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Actemra
Dosage: dosis: 560 mg hver 4. uge
Indication: Rheumatoid Arthritis
Start date: 2010-08-01
End date: 2012-02-23
Methotrexate
Dosage: behandling stoppet pga. mors, drug reported as emthexate
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Prednisolone
Dosage: behandling stoppet pga. mors
Indication: Rheumatoid Arthritis
Start date: 2002-04-04
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Methotrexate
Dosage: 3000 mg/m2; administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Methotrexate
Dosage: as part of copadm2 and cym1
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm1
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Methotrexate
Dosage: as part of copadm2 and cym1
Methotrexate
Dosage: administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm1
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2
Cyclophosphamide
Dosage: 300 mg/m2 as part of cop
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: continuous infusion of 100 mg/m2 daily for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: administered once with hydrocortisone as part of cym1
Doxorubicin HCL
Dosage: as part of copadm1
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Dosage: as part of copadm2
Hydrocortisone
Dosage: administered once with cytarabine as part of cym1
Hydrocortisone
Dosage: administered with methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm2 and cym1
Methotrexate
Dosage: administered with hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: as part of copadm1
Prednisolone
Dosage: 60 mg/m2/day for 7 days as part of cop
Indication: Burkitt's Lymphoma Stage III
Prednisolone
Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2
Rituximab
Dosage: five total doses; cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: as part of copadm2
Vincristine
Dosage: as part of copadm1
Vincristine
Dosage: as part of cop
Indication: Burkitt's Lymphoma Stage III
Possible Prednisolone side effects in
Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-06-20
Patient:
Reactions: Sepsis, Cytomegalovirus Infection, Human Polyomavirus Infection, Graft Loss
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Indication: Prophylaxis Against Transplant Rejection
Azathioprine
Administration route: Oral
Cellcept
Indication: Prophylaxis Against Transplant Rejection
Prednisolone
Dosage: for 2 days
Prednisolone
Administration route: Oral
Prednisolone
Indication: Prophylaxis Against Transplant Rejection
Prednisolone
Administration route: Oral
Prednisolone
Dosage: for 2 days
Tacrolimus
Tacrolimus
Indication: Prophylaxis Against Transplant Rejection
Other drugs received by patient: Valtrex
Possible Prednisolone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Pancytopenia, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 250 mg/m2, bid for 6 doses
Cyclophosphamide
Dosage: 250 mg/m2, bid for 6 doses
Cyclophosphamide
Dosage: 300 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: 100 mg/m2, for 5 days
Indication: Burkitt's Lymphoma Stage III
Cytarabine
Dosage: unknown
Doxorubicin HCL
Dosage: 30 mg/m2, unk
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Dosage: intrathecally twice
Hydrocortisone
Hydrocortisone
Dosage: intrathecally twice
Hydrocortisone
Dosage: unknwon
Methotrexate
Dosage: 1500 mg/m2, unk
Methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Dosage: intrathecally twice
Methotrexate
Dosage: intrathecally twice
Methotrexate
Dosage: 1500 mg/m2, unk
Methotrexate
Dosage: 30000 mg/m2, unk
Methotrexate
Prednisolone
Dosage: 60 mg/m2, for 5 days, then taper over 3 days
Prednisolone
Dosage: 60 mg/m2, for 5 days then taper over 3 days
Prednisolone
Dosage: 60 mg/m2, per day for 7 days
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: every 2-4 weeks for 5 total doses with cumulative dose of 1875 mg/m2
Indication: Burkitt's Lymphoma Stage III
Rituximab
Dosage: cumulative dose of 1875 mg/m2
Vincristine
Dosage: 2 mg/m2, unk
Vincristine
Dosage: 1 mg/m2, unk
Indication: Burkitt's Lymphoma Stage III
Vincristine
Dosage: 1 mg/m2, unk
Possible Prednisolone side effects in 76 year old female
Reported by a physician from Japan on 2012-06-19
Patient: 76 year old female
Reactions: Stomatitis, Small Intestinal Perforation, Pleurisy, Diarrhoea Haemorrhagic, Sepsis, Cholecystitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Fludara
Dosage: unk
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2010-09-01
End date: 2011-02-01
Prednisolone
Dosage: unk
Indication: non-Hodgkin's Lymphoma Recurrent
Rituximab
Dosage: unk
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2010-09-01
End date: 2011-02-01
Possible Prednisolone side effects in
Reported by a physician from Japan on 2012-06-13
Patient:
Reactions: Jaundice, Stomatitis, Small Intestinal Perforation, Pleurisy, Sepsis, Diarrhoea Haemorrhagic, Cholecystitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Fludara
Dosage: unk
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2010-09-01
End date: 2011-02-01
Prednisolone
Dosage: unk
Indication: non-Hodgkin's Lymphoma Recurrent
Rituximab
Dosage: unk
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2010-09-01
End date: 2011-02-01
Possible Prednisolone side effects in 68 year old male
Reported by a individual with unspecified qualification from Chile on 2012-06-05
Patient: 68 year old male
Reactions: Rectal Haemorrhage, Sepsis, Pancytopenia, Neutropenia, Ascites
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclosporine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Methylprednisolone
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Page 1 Next >>
|
